https://www.selleckchem.com/pr....oducts/shin1-rz-2994
743) and no significant increase in retention. Post hoc analysis suggests insurance coverage may be influencing outcomes. Conclusions Despite MOUD being a standard of care for OUD, MOUD is particularly under-utilized in residential treatment. Further research should focus on how best to integrate MOUD within short-term residential treatment and to explore the potential viability of MOUD in long-term residential programs. Given the risk of overdose following residential treatment, for at least short-term residential programs, this